Get startedLog in
    Picture of Aura Biosciences logo

    AURA — Aura Biosciences News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareAdventurousMid CapNeutral
    All News

    Brief: Aura Announces Global Phase 3 Trial Design With Suprachoroidal Route

    Picture of Aura Biosciences logoAura Biosciences
    10/11/2022 12:56
    Nov 10 (Reuters) - Aura Biosciences Inc  AURA.O :
    * AURA ANNOUNCES GLOBAL PHASE 3 TRIAL DESIGN WITH
SUPRACHOROIDAL
ROUTE OF ADMINISTRATION BASED ON POSITIVE PHASE 2 INTERIM DATA
OF BELZUPACAP SAROTALOCAN IN EARLY-STAGE CHOROIDAL MELANOMA
    * AURA BIOSCIENCES INC - CO HAS ALIGNED WITH REGULATORY
AGENCIES
AND FINALIZED DESIGN OF GLOBAL PHASE 3 TRIAL

Source text for Eikon:  ID:nBw2FcsZVa 
Further company coverage:  AURA.O 
 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on Aura Biosciences

    See all news